By
Drug Target Review2025-02-21T09:00:18
A new UCLA study reveals that DNA mismatch repair genes play a crucial role in Huntington’s disease by driving neuronal damage and motor impairments. Targeting these genes, especially Msh3 and Pms1, could offer promising therapeutic avenues for the disease.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-19T08:26:00Z
2026-06-17T09:14:00Z
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2026-06-02T15:00:00 2026-06-02T16:00:00
Sponsored by Danaher Life Sciences
2024-02-07T14:34:33
Sponsored by BellBrook Labs
2023-05-10T11:18:16
Sponsored by Revvity
2026-03-25T15:00:00 2026-03-25T16:00:00
Sponsored by Yokogawa
2023-03-08T16:29:20
Sponsored by Bio-Techne
Site powered by Webvision Cloud